ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration

Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation

Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143

Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia

Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623

ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors

Boillée, S., Velde, C. V., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,476

Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration

Oosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Dorpe, J. V., Hellings, P., Gorselink, M., Heymans, S., et al. (2001) · Nature Genetics · doi:10.1038/88842 · Cited by 1,007

VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death

Lambrechts, D., Storkebaum, E., Morimoto, M., Del‐Favero, J., Smet, F. D., Marklund, S. L., Wyns, S., Thijs, V., Andersson, J., van Marion, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1211 · Cited by 853

Neurovascular mechanisms of Alzheimer's neurodegeneration

Zlokovic, B. V. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.02.001 · Cited by 770

Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF

Pun, S., Santos, A. F., Saxena, S., Xu, L., & Caroni, P. (2006) · Nature Neuroscience · doi:10.1038/nn1653 · Cited by 689

Axonal damage markers in cerebrospinal fluid are increased in ALS

Brettschneider, J., Petzold, A., Süßmuth, S. D., Ludolph, A. C., & Tumani, H. (2006) · Neurology · doi:10.1212/01.wnl.0000203120.85850.54 · Cited by 261

Evidence of Compromised Blood-Spinal Cord Barrier in Early and Late Symptomatic SOD1 Mice Modeling ALS

Garbuzova-Davis, S. N., Saporta, S., Haller, E. M., Kolomey, I., Bennett, S. P., Potter, H., & Sanberg, P. R. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001205 · Cited by 253

Ultrastructure of blood–brain barrier and blood–spinal cord barrier in SOD1 mice modeling ALS

Garbuzova-Davis, S., Haller, E., Saporta, S., Kolomey, I., Nicosia, S. V., & Sanberg, P. R. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.044 · Cited by 239

Reactive Oxygen Species in Inflammation and Tissue Injury

Mittal, M., Siddiqui, M. R., Tran, K., Reddy, S. P., & Malik, A. B. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5149 · Cited by 4,897

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076

Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders

Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969

The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease

Iadecola, C. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.030 · Cited by 2,480

Development, maintenance and disruption of the blood-brain barrier

Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452

Blood-Brain Barrier: From Physiology to Disease and Back

Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312

Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging

Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448

Reactive Gliosis and the Multicellular Response to CNS Damage and Disease

Burda, J. E., & Sofroniew, M. V. (2014) · Neuron · doi:10.1016/j.neuron.2013.12.034 · Cited by 1,500

Pericytes of the neurovascular unit: key functions and signaling pathways

Sweeney, M. D., Ayyadurai, S., & Zlokovic, B. V. (2016) · Nature Neuroscience · doi:10.1038/nn.4288 · Cited by 1,125

Mfsd2a is critical for the formation and function of the blood-brain barrier

Ben-Zvi, A., Lacoste, B., Kur, E., Andreone, B. J., Mayshar, Y., Yan, H., & Gu, C. (2014) · Nature · doi:10.1038/nature13324 · Cited by 1,037

Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond

Ilieva, H., Polymenidou, M., & Cleveland, D. W. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908164 · Cited by 1,008

Central nervous system pericytes in health and disease

Winkler, E. A., Bell, R. D., & Zlokovic, B. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2946 · Cited by 962

The changing scene of amyotrophic lateral sclerosis

Robberecht, W., & Philips, T. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3430 · Cited by 957

Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease

Bell, R. D., & Zloković, B. V. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0522-3 · Cited by 883

NG2+ CNS Glial Progenitors Remain Committed to the Oligodendrocyte Lineage in Postnatal Life and following Neurodegeneration

Kang, S. H., Fukaya, M., Yang, J. K., Rothstein, J. D., & Bergles, D. E. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.009 · Cited by 815

The blood–brain barrier in health and disease

Daneman, R. (2012) · Annals of Neurology · doi:10.1002/ana.23648 · Cited by 794

Brain metabolism in health, aging, and neurodegeneration

Camandola, S., & Mattson, M. P. (2017) · The EMBO Journal · doi:10.15252/embj.201695810 · Cited by 752

The blood-brain barrier in aging and neurodegeneration

Knox, E. G., Aburto, M. R., Clarke, G., Cryan, J. F., & O’Driscoll, C. M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01511-z · Cited by 738

Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease

Argaw, A. T., Asp, L., Zhang, J., Navrazhina, K., Pham, T., Mariani, J. N., Mahase, S., Dutta, D. J., Seto, J., Kramer, E. G., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60842 · Cited by 733

Alzheimer’s disease: A matter of blood–brain barrier dysfunction?

Montagne, A., Zhao, Z., & Zlokovic, B. V. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171406 · Cited by 672

The blood-brain barrier: an engineering perspective

Wong, A. D., Ye, M., Levy, A. F., Rothstein, J. D., Bergles, D. E., & Searson, P. C. (2013) · Frontiers in Neuroengineering · doi:10.3389/fneng.2013.00007 · Cited by 662

VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown

Argaw, A. T., Gurfein, B. T., Zhang, Y., Zameer, A., & John, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808698106 · Cited by 666

Brain Tissue Responses to Neural Implants Impact Signal Sensitivity and Intervention Strategies

Kozai, T. D. Y., Jaquins-Gerstl, A. S., Vazquez, A. L., Michael, A. C., & Cui, X. T. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn500256e · Cited by 622

Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target

Barber, S. C., & Shaw, P. J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.018 · Cited by 647

A role for motoneuron subtype–selective ER stress in disease manifestations of FALS mice

Saxena, S., Cabuy, E., & Caroni, P. (2009) · Nature Neuroscience · doi:10.1038/nn.2297 · Cited by 567

The dynamic blood–brain barrier

Keaney, J., & Campbell, M. (2015) · The FEBS Journal · doi:10.1111/febs.13412 · Cited by 616

Selective Neuronal Vulnerability in Neurodegenerative Diseases: from Stressor Thresholds to Degeneration

Saxena, S., & Caroni, P. (2011) · Neuron · doi:10.1016/j.neuron.2011.06.031 · Cited by 578

The blood–spinal cord barrier: Morphology and Clinical Implications

Bartanusz, V., Ježová, D., Alajajian, B., & Digicaylioglu, M. H. (2011) · Annals of Neurology · doi:10.1002/ana.22421 · Cited by 495

Lipid Oxidation and Peroxidation in CNS Health and Disease: From Molecular Mechanisms to Therapeutic Opportunities

Adibhatla, R. M., & Hatcher, J. F. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2668 · Cited by 480

Motor Neuron Diversity in Development and Disease

Kanning, K. C., Kaplan, A., & Henderson, C. E. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135722 · Cited by 513

The Role of Environmental Exposures in Neurodegeneration and Neurodegenerative Diseases

Cannon, J. R., & Greenamyre, J. T. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr239 · Cited by 475

Neurological Diseases in Relation to the Blood–Brain Barrier

Rosenberg, G. A. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.197 · Cited by 454

Blood–spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis

Winkler, E. A., Sengillo, J. D., Sullivan, J. S., Henkel, J. S., Appel, S. H., & Zlokovic, B. V. (2013) · Acta Neuropathologica · doi:10.1007/s00401-012-1039-8 · Cited by 354

Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice

Yamanaka, K., Boillee, S., Roberts, E. A., Garcia, M. L., McAlonis-Downes, M., Mikse, O. R., Cleveland, D. W., & Goldstein, L. S. B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802556105 · Cited by 309

Dysfunction of the neurovascular unit in ischemic stroke and neurodegenerative diseases: An aging effect

Cai, W., Zhang, K., Li, P., Zhu, L., Xu, J., Yang, B., Hu, X., Lu, Z., & Chen, J. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.006 · Cited by 296

The Pericyte: A Forgotten Cell Type with Important Implications for A lzheimer's Disease?

Winkler, E. A., Sagare, A. P., & Zloković, B. V. (2014) · Brain Pathology · doi:10.1111/bpa.12152 · Cited by 284

Barrier function in the peripheral and central nervous system—a review

Reinhold, A., & Rittner, H. L. (2016) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1920-8 · Cited by 279

Glial cells in amyotrophic lateral sclerosis

Philips, T., & Rothstein, J. D. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.05.015 · Cited by 266

Neurovascular Dysfunction and Faulty Amyloid -Peptide Clearance in Alzheimer Disease

Sagare, A. P., Bell, R. D., & Zlokovic, B. V. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011452 · Cited by 251

Neurovascular Unit Dysfunction and Neurodegenerative Disorders

Yu, X., Ji, C., & Shao, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00334 · Cited by 244

The Amyotrophic Lateral Sclerosis 8 Protein VAPB Is Cleaved, Secreted, and Acts as a Ligand for Eph Receptors

Tsuda, H., Han, S. M., Yang, Y., Tong, C., Qi, L. Y., Mohan, K., Haueter, C. M., Zoghbi, A. W., Harati, Y., Kwan, J. Y., et al. (2008) · Cell · doi:10.1016/j.cell.2008.04.039 · Cited by 243

Brain Endothelial Cells Are Exquisite Sensors of Age-Related Circulatory Cues

Chen, M. B., Yang, A. C., Yousef, H., Lee, D., Chen, W., Schaum, N., Lehallier, B., Quake, S. R., & Wyss-Coray, T. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.03.012 · Cited by 233

Impaired blood–brain/spinal cord barrier in ALS patients

Garbuzova-Davis, S. N., Hernandez‐Ontiveros, D. G., Rodrigues, M. C. O., Haller, E. M., Frisina-Deyo, A. J., Mirtyl, S., Sallot, S. A., Saporta, S., Borlongan, C. V., & Sanberg, P. R. (2012) · Brain Research · doi:10.1016/j.brainres.2012.05.056 · Cited by 242

Blood–Spinal Cord Barrier Pericyte Reductions Contribute to Increased Capillary Permeability

Winkler, E. A., Sengillo, J. D., Bell, R. D., Wang, J., & Zlokovic, B. V. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.113 · Cited by 226

Blood-Brain Barrier Dysfunction in CNS Disorders and Putative Therapeutic Targets: An Overview

Archie, S. R., Shoyaib, A. A., & Cucullo, L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111779 · Cited by 244

Blood–spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice

Winkler, E. A., Sengillo, J. D., Sagare, A. P., Zhao, Z., Ma, Q., Zuniga, E., Wang, Y., Zhong, Z., Sullivan, J. S., Griffin, J. H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401595111 · Cited by 238

Anesthesia and Surgery Impair Blood–Brain Barrier and Cognitive Function in Mice

Yang, S., Gu, C.-P., Mandeville, E. T., Dong, Y., Esposito, E., Zhang, Y., Yang, G., Shen, Y., Fu, X., Lo, E. H., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00902 · Cited by 237

Cellular Senescence, Vascular Disease, and Aging

Kovacic, J. C., Moreno, P., Nabel, E. G., Hachinski, V., & Fuster, V. (2011) · Circulation · doi:10.1161/circulationaha.110.009118 · Cited by 223

Emerging roles of PGE2 receptors in models of neurological disease

Andreasson, K. I. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.04.003 · Cited by 225

Astrocyte-Derived TGF-β1 Accelerates Disease Progression in ALS Mice by Interfering with the Neuroprotective Functions of Microglia and T Cells

Endo, F., Komine, O., Fujimori-Tonou, N., Katsuno, M., Jin, S., Watanabe, S., Sobue, G., Dezawa, M., Wyss-Coray, T., & Yamanaka, K. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.053 · Cited by 207

Cellular Senescence, Vascular Disease, and Aging

Kovacic, J. C., Moreno, P., Hachinski, V., Nabel, E. G., & Fuster, V. (2011) · Circulation · doi:10.1161/circulationaha.110.007021 · Cited by 209

Therapeutic AAV9-mediated Suppression of Mutant SOD1 Slows Disease Progression and Extends Survival in Models of Inherited ALS

Foust, K. D., Salazar, D. L., Likhite, S. B., Ferraiuolo, L., Ditsworth, D., Ilieva, H. S., Meyer, K., Schmelzer, L., Braun, L., Cleveland, D. W., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.211 · Cited by 211

The impact of cerebrovascular aging on vascular cognitive impairment and dementia

Yang, T., Sun, Y., Lu, Z., Leak, R. K., & Zhang, F. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.007 · Cited by 214

Microglia centered pathogenesis in ALS: insights in cell interconnectivity

Brites, D. M. T. O., & Vaz, A. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00117 · Cited by 213

Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases

Grammas, P., Martinez, J. M., & Miller, B. B. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001918 · Cited by 212

Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis

Miyazaki, K., Ohta, Y., Nagai, M., Morimoto, N., Kurata, T., Takehisa, Y., Ikeda, Y., Matsuura, T., & Abe, K. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22594 · Cited by 197

Neurodegeneration and the neurovascular unit

Zloković, B. V. (2010) · Nature Medicine · doi:10.1038/nm1210-1370 · Cited by 193

Stem Cell Transplantation in Amyotrophic Lateral Sclerosis Patients: Methodological Approach, Safety, and Feasibility

Martínez, H. R., Molina-López, J. F., González‐Garza, M. T., Moreno-Cuevas, J. E., Caro-Osorio, E., Gil-Valadez, A. H., Gutiérrez‐Jiménez, E., Zazueta, O. E., Meza, J. A., Couret-Alcaraz, P., et al. (2011) · Cell Transplantation · doi:10.3727/096368911x582769 · Cited by 183

Control of Motoneuron Survival by Angiogenin

Kieran, D., Sebastià, J., Greenway, M. J., King, M. A., Connaughton, D. M., Concannon, C. G., Fenner, B. J., Hardiman, O. M., & Prehn, J. H. M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3399-08.2008 · Cited by 183

Inflammation and neurovascular changes in amyotrophic lateral sclerosis

Evans, M. C., Couch, Y., Sibson, N. R., & Turner, M. R. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.10.008 · Cited by 174

Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells

Zhong, Z., Ilieva, H., Hallagan, L., Bell, R., Singh, I., Paquette, N., Thiyagarajan, M., Deane, R., Fernandez, J. A., Lane, S., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38476 · Cited by 176

Characterization of early pathogenesis in the SOD 1G93A mouse model of ALS: part II, results and discussion

Vinsant, S., Mansfield, C., Jimenez‐Moreno, R., Moore, V. D. G., Yoshikawa, M., Hampton, T. G., Prevette, D., Caress, J., Oppenheim, R. W., & Milligan, C. (2013) · Brain and Behavior · doi:10.1002/brb3.142 · Cited by 172

The Complex Molecular Biology of Amyotrophic Lateral Sclerosis (ALS)

Redler, R. L., & Dokholyan, N. V. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00002-3 · Cited by 172

Human iPSC-Derived Endothelial Cells and Microengineered Organ-Chip Enhance Neuronal Development

Sances, S., Ho, R., Vatine, G. D., West, D., Laperle, A., Meyer, A. S., Godoy, M. I., Kay, P., Mandefro, B., Hatata, S., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.02.012 · Cited by 170

Loss of ALS-associated TDP-43 in zebrafish causes muscle degeneration, vascular dysfunction, and reduced motor neuron axon outgrowth

Schmid, B., Hruscha, A., Hogl, S., Banzhaf‐Strathmann, J., Strecker, K., van der Zee, J., Teucke, M., Eimer, S., Hegermann, J., Kittelmann, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218311110 · Cited by 178

A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease

Ramesh, T., Lyon, A. N., Pineda, R., Wang, C., Janssen, P. M. L., Canan, B. D., Burghes, A. H. M., & Beattie, C. E. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.005538 · Cited by 164

On the assessment of cerebrovascular reactivity using hypercapnia BOLD MRI

Yezhuvath, U. S., Lewis‐Amezcua, K., Varghese, R., Xiao, G., & Lu, H. (2009) · NMR in Biomedicine · doi:10.1002/nbm.1392 · Cited by 157

Impaired blood–brain and blood–spinal cord barriers in mutant SOD1-linked ALS rat

Nicaise, C., Mitrecic, D., Demetter, P., De Decker, R., Authelet, M., Boom, A., & Pochet, R. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.018 · Cited by 168

Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platforms

Oksanen, M., Lehtonen, Š., Jaronen, M., Goldsteins, G., Hämäläinen, R. H., & Koıstınaho, J. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03111-7 · Cited by 166

In vitro modeling of the neurovascular unit: advances in the field

Bhalerao, A., Sivandzade, F., Archie, S. R., Chowdhury, E. A., Noorani, B., & Cucullo, L. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00183-7 · Cited by 154

Effects of caspase-1 knockout on chronic neural recording quality and longevity: Insight into cellular and molecular mechanisms of the reactive tissue response

Kozai, T. D. Y., Li, X., Bodily, L. M., Caparosa, E. M., Zenonos, G. A., Carlisle, D. L., Friedlander, R. M., & Cui, X. T. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.08.006 · Cited by 136

Blood-CNS Barrier Impairment in ALS patients versus an animal model

Garbuzova-Davis, S. N., & Sanberg, P. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00021 · Cited by 152

Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis

Sutedja, N. A., van der Schouw, Y. T., Fischer, K., Sizoo, E. M., Huisman, M. H. B., Veldink, J. H., & van den Berg, L. H. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.236752 · Cited by 144

Occludin Protein Family: Oxidative Stress and Reducing Conditions

Blasig, I. E., Bellmann, C., Cording, J., Vecchio, G. D., Zwanziger, D., Huber, O., & Haseloff, R. F. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3542 · Cited by 142

DECREASED mRNA EXPRESSION OF TIGHT JUNCTION PROTEINS IN LUMBAR SPINAL CORDS OF PATIENTS WITH ALS

Henkel, J. S., Beers, D. R., Wen, S., Bowser, R., & Appel, S. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a41228 · Cited by 153

Dysfunctional Cell-Cell Signaling in the Neurovascular Unit as a Paradigm for Central Nervous System Disease

Guo, S., & Lo, E. H. (2008) · Stroke · doi:10.1161/strokeaha.108.534388 · Cited by 135

Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis

Dodge, J. C., Treleaven, C. M., Pacheco, J., Cooper, S., Bao, C., Abraham, M., Cromwell, M. A., Sardi, S. P., Chuang, W., Sidman, R. L., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508767112 · Cited by 134

Sporadic ALS has compartment-specific aberrant exon splicing and altered cell–matrix adhesion biology

Rabin, S. J., Kim, J. M., Baughn, M. W., Libby, R. T., Kim, Y. J., Fan, Y., Libby, R. T., Spada, A. R. L., Stone, B. C., & Ravits, J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp498 · Cited by 137

Inflammation in ALS and SMA: Sorting out the good from the evil

Papadimitriou, D. A., Verche, V. L., Jacquier, A., Ikiz, B., Przedborski, S., & Ré, D. B. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.005 · Cited by 137

Amyotrophic lateral sclerosis: A neurovascular disease

Garbuzova-Davis, S. N., Rodrigues, M. C. O., Hernandez‐Ontiveros, D. G., Louis, M. K., Willing, A. E., Borlongan, C. V., & Sanberg, P. R. (2011) · Brain Research · doi:10.1016/j.brainres.2011.04.049 · Cited by 128

Cytoprotective protein C pathways and implications for stroke and neurological disorders

Zlokovic, B. V., & Griffin, J. H. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.01.005 · Cited by 128

Rodent models of TDP-43: Recent advances

Tsao, W., Jeong, Y. H., Lin, S. Z., Ling, J. P., Price, D. L., Chiang, P., & Wong, P. C. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.031 · Cited by 129

Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis

Dodge, J. C., Treleaven, C. M., Fidler, J. A., Tamsett, T. J., Bao, C., Searles, M., Taksir, T. V., Misra, K., Sidman, R. L., Cheng, S. H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308421110 · Cited by 124

Developmental and pathological angiogenesis in the central nervous system

Vallon, M., Chang, J., Zhang, J. H., & Kuo, C. J. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1625-0 · Cited by 125

Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules

Harilal, S., Jose, J., Parambi, D. G. T., Kumar, R., Unnikrishnan, M. K., Uddin, M. S., Mathew, G. E., Pratap, R., Marathakam, A., & Mathew, B. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.03.018 · Cited by 127

Altered perivascular fibroblast activity precedes ALS disease onset

Månberg, A., Skene, N., Sanders, F., Trusohamn, M., Remnestål, J., Szczepińska, A., Aksoylu, I. S., Lönnerberg, P., Ebarasi, L., Wouters, S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01295-9 · Cited by 120

Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor

Zhu, D., Wang, Y., Singh, I., Bell, R. D., Deane, R., Zhong, Z., Sagare, A. P., Winkler, E. A., & Zloković, B. V. (2010) · Blood · doi:10.1182/blood-2010-01-262386 · Cited by 118

Amyotrophic Lateral Sclerosis: A Neurodegenerative Motor Neuron Disease With Ocular Involvement

Rojas, P., Ramirez, A. I., Fernández‐Albarral, J. A., López‐Cuenca, I., Salobrar‐García, E., Cadena, M., Elvira‐Hurtado, L., Salazar, J. J., de Hoz, R., & Ramirez, J. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.566858 · Cited by 117

Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model

Nizzardo, M., Simone, C., Rizzo, F., Ruggieri, M., Salani, S., Riboldi, G. M., Faravelli, I., Zanetta, C., Bresolin, N., Comi, G. P., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt425 · Cited by 113

Glial Cells in Amyotrophic Lateral Sclerosis

Lasiene, J., & Yamanaka, K. (2011) · Neurology Research International · doi:10.1155/2011/718987 · Cited by 110

Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis

Arias, H. R., Richards, V. E., Ng, D., Ghafoori, M. E., Le, V., & Mousa, S. A. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.01.013 · Cited by 109

Degeneration and repair in central nervous system disease

Lo, E. H. (2010) · Nature Medicine · doi:10.1038/nm.2226 · Cited by 111

Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex

Aronica, E., Baas, F., Iyer, A. M., ten Asbroek, A. L. M. A., Morello, G., & Cavallaro, S. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.002 · Cited by 106

Changes in the astrocytic aquaporin‐4 and inwardly rectifying potassium channel expression in the brain of the amyotrophic lateral sclerosis SOD1 G93A rat model

Bataveljić, D., Nikolic, L. M., Milosevic, M. M., Todorović, N. V., & Anđjus, P. R. (2012) · Glia · doi:10.1002/glia.22414 · Cited by 106

The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia

Radford, R. A. W., Morsch, M., Rayner, S. L., Cole, N. J., Pountney, D. L., & Chung, R. S. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00414 · Cited by 105

Pharmacological inhibition of complement C5a‐C5a1 receptor signalling ameliorates disease pathology in the hSOD1G93A mouse model of amyotrophic lateral sclerosis

Lee, J. D., Kumar, V., Fung, J. N., Ruitenberg, M. J., Noakes, P. G., & Woodruff, T. M. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13730 · Cited by 100

Biphasic Mechanisms of Neurovascular Unit Injury and Protection in CNS Diseases

Maki, T., Hayakawa, K., Pham, L. D., Xing, C., Lo, E. H., & Arai, K. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312030004 · Cited by 103

Interleukin-25 Expressed by Brain Capillary Endothelial Cells Maintains Blood-Brain Barrier Function in a Protein Kinase Cϵ-dependent Manner

Sonobe, Y., Takeuchi, H., Kataoka, K., Li, H., Jin, S., Mimuro, M., Hashizume, Y., Sano, Y., Kanda, T., Mizuno, T., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.025940 · Cited by 99

Matrix Metalloproteinase-3 Promotes Early Blood–Spinal Cord Barrier Disruption and Hemorrhage and Impairs Long-Term Neurological Recovery after Spinal Cord Injury

Lee, J. Y., Choi, H. Y., Ahn, H., Ju, B. G., & Yune, T. Y. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.07.016 · Cited by 103

Vascular D efects and S pinal C ord H ypoxia in S pinal M uscular A trophy

Somers, E., Lees, R. D., Hoban, K., Sleigh, J. N., Zhou, H., Muntoni, F., Talbot, K., Gillingwater, T. H., & Parson, S. H. (2015) · Annals of Neurology · doi:10.1002/ana.24549 · Cited by 104

Blood–spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice

Winkler, E. A., Sengillo, J. D., Sagare, A. P., Zhao, Z., Ma, Q., Zuniga, E., Wang, Y., Zhong, Z., Sullivan, J. S., Griffin, J. H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401595111 · Cited by 238

Blood-CNS Barrier Impairment in ALS patients versus an animal model

Garbuzova-Davis, S. N., & Sanberg, P. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00021 · Cited by 152

Neurovascular unit pathology is observed very early in disease progression in the mutant SOD1G93A mouse model of amyotrophic lateral sclerosis

Yoshikawa, M., Aizawa, S., Oppenheim, R. W., & Milligan, C. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114084 · Cited by 22

Expression of the ALS-Causing Variant hSOD1 G93A Leads to an Impaired Integrity and Altered Regulation of Claudin-5 Expression in an in Vitro Blood–Spinal Cord Barrier Model

Meister, S., Storck, S. E., Hameister, E., Behl, C., Weggen, S., Clement, A. M., & Pietrzik, C. U. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.57 · Cited by 27

Massive Mitochondrial Degeneration in Motor Neurons Triggers the Onset of Amyotrophic Lateral Sclerosis in Mice Expressing a Mutant SOD1

Kong, J., & Xu, Z. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03241.1998 · Cited by 723